Jauhar et al found that small improvements in symptoms disappeared when they were assessed blind which is where the assessors didn’t know whether the patients were taking therapy or were in a control group.
A meta analysis also found similar design problems as different place recommended different treatments e.g. england and wales recommended CBTp and scotland recommended antipsychotics.
Therefore there are inconsistencies in the effectiveness and appropriateness of treatment which leads to the questioning of the therapy.